Source: Health Products and Food Branch (CA) Revision Year: 2018
MYDFRIN.
MYDFRIN (phenylephrine hydrochloride ophthalmic solution) is a sterile ophthalmic solution containing:
Medicinal Ingredient: Phenylephrine HCl 2.5% w/v.
Non-medicinal Ingredients: Benzalkonium Chloride 0.01% w/v (preservative), Boric Acid, Sodium Bisulfite, Edetate Disodium, Sodium Hydroxide and/or Hydrochloric Acid (to adjust pH), Purified Water.
Phenylephrine hydrochloride is used for local ocular disorders because of its vasoconstrictor and mydriatic action. The usefulness of phenylephrine hydrochloride in ophthalmology is due to its rapid effect, moderately prolonged action, and effectiveness even when administered repeatedly, as well as to the fact that it produces little rebound vasodilation. In addition, undesirable systemic side effects are uncommon. As an alpha receptor stimulator, MYDFRIN* produces pupillary dilatation and vasoconstriction.
Phenylephrine Hydrochloride Ophthalmic Solution 2.5% w/v.
Vasoconstrictor and Mydriatic for Use in Ophthalmology.
PHYSICIANS SHOULD COMPLETELY FAMILIARIZE THEMSELVES WITH THE COMPLETE CONTENTS OF THIS LEAFLET BEFORE PRESCRIBING PHENYLEPHRINE HYDROCHLORIDE.
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
Alcon Canada Inc., 2665 Meadowpine Blvd., Mississauga, ON, Canada L5N 8C7 215664 |
Date of revision:
May 28, 2018 |
| Drug | Countries | |
|---|---|---|
| MYDFRIN | Canada, Singapore, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
